Concepedia

Author

Hao Jiang

Peking University People's HospitalORCID

Also Known As

G Cosgrove, H Jiang, H. Jiang, H. jiang, HAO JIANG, Hao Jiang, Haoye JIANG, Haoyun Jiang, Hua-sha Jiang, Jiang Hao

275

Publications

2.4K

Citations

23

H-Index

55

Concepts

All Affiliations

Peking University People's HospitalPeking UniversityCenter for Life SciencesBeijing HospitalImperial College London
HJ

About

Hao Jiang is an author at Peking University People's Hospital specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

20

532

2

Health Sciences

8

8

247

3

Engineering

4

4

113

4

Public Health

1

1

17

5

Biostatistics

1

1

33

Hao Jiang

×

57

Publications

1.9K

Citations

23

H-Index

YearCitations

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Hong‐Hu Zhu, Xiaohui Zhang, Ya‐Zhen Qin,

Blood

2013

321

Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial

Hong‐Hu Zhu, Depei Wu, Jie Jin,

Journal of Clinical Oncology

2013

177

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

Xiao‐Jun Huang, Hong‐Hu Zhu, Ying‐Jun Chang,

Blood

2012

122

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Qian Jiang, Lan‐Ping Xu, Dai‐Hong Liu,

Blood

2011

82

Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: A comprehensive large-scale study from a single Chinese center

Ya‐Zhen Qin, Hong‐Hu Zhu, Qian Jiang,

Leukemia Research

2014

75

Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

Feier Feng, Ru Feng, Min Wang,

The Lancet Haematology

2017

49

Prevalence and outcomes of uncommon <i><scp>BCR</scp>‐<scp>ABL</scp>1</i> fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre

Ya‐Zhen Qin, Qian Jiang, Hao Jiang,

British Journal of Haematology

2018

49

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

Ya‐Zhen Qin, Shanshan Chen, Bin Jiang,

Annals of Hematology

2010

46

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission

Meng Lv, Yu Wang, Ying‐Jun Chang,

Clinical Cancer Research

2018

44

Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Jing Wang, Qian Jiang, Lan‐Ping Xu,

Biology of Blood and Marrow Transplantation

2017

42

Page 1